Individual tests

A Pap smear is where cells are collected from the cervix and sent to a lab to check for signs of cancer or for HPV, a virus that can cause cervical cancer. Pap smears and HPV tests are cervical cancer screening tests that look for cancer before you have any symptoms.
Pathtezt is intended as a replacement for the conventional method of Pap smear tests in screening for atypical cells, cervical cancer, or its precursor lesions (LSIL, HSIL). These smears are high-quality and cost-effective.
Preeclampsia is a high blood pressure (hypertension) disorder that can occur after the 20th week of pregnancy. Complications of preeclampsia may include: fetal growth restriction, preterm birth, and placental abruption. PlGF assay, in conjunction with sFlt-1 assay, other diagnostic tests, and clinical information, is for use in diagnosing preeclampsia.
Preeclampsia is a high blood pressure (hypertension) disorder that can occur after the 20th week of pregnancy. Complications of preeclampsia may include fetal growth restriction, preterm birth, and placental abruption. The PlGF assay is used with the sFlt-1 assay, other diagnostic tests, and clinical information to diagnose preeclampsia.
Preeclampsia is a high blood pressure (hypertension) disorder that can occur after the 20th week of pregnancy. Complications of preeclampsia may include: fetal growth restriction, preterm birth, and placental abruption. PlGF assay, in conjunction with sFlt-1 assay, other diagnostic tests, and clinical information, is for use in diagnosing preeclampsia.
Our semen analysis uses the new FDA-certified automated semen analysis system, SQA-IQ. The evaluation criteria are based on the latest WHO 6th Edition for Human Semen guidelines. This test determines male fertility status based on testing semen samples. Blood tests also need to be done to comprehensively analyse male infertility.
T3 is one of two major hormones made by your thyroid, a small gland located near the throat. It helps regulate your energy use, weight, body temperature, muscle strength, and nervous system. This test helps diagnose, assess and monitor thyroid disorders, such as an overactive or underactive thyroid gland and aids diagnoses of pituitary gland disorders.
Thyroxine (T4) is a thyroid hormone affecting your weight, heart, body temperature, and muscle strength. A T4 test can check how well your thyroid is working. It also helps diagnose and monitor thyroid disease and conditions like an underactive or overactive thyroid.
Thyroglobulin is a thyroid protein. This test is mostly used to monitor, but not to diagnose, patients with well-differentiated thyroid cancers. The measurement of thyroglobulin after thyroidectomy and ablation of the thyroid gland is useful for determining metastasis. It may also help diagnose hyperthyroidism and hypothyroidism, which are common non-cancer thyroid conditions.
Thyroglobulin is a protein that your thyroid produces. Antithyroglobulin antibodies can indicate thyroid gland damage caused by the immune system. They may be measured in suspected cases of thyroid inflammation. Measuring thyroglobulin antibody levels after thyroid cancer treatment can help your provider monitor recurrence.
Antibodies are immune system proteins that fight foreign substances like viruses and bacteria. Sometimes antibodies attack the body's cells, tissues, and organs by mistake, known as an autoimmune response. When thyroid antibodies attack healthy thyroid cells, it can lead to Hashimoto's or autoimmune thyroiditis. This test measures the level of thyroid antibodies in your blood.
Antibodies are immune system proteins that fight foreign substances like viruses and bacteria. Sometimes antibodies attack the body's cells, tissues, and organs by mistake, known as an autoimmune response. When thyroid antibodies attack healthy thyroid cells, it can lead to Hashimoto's or autoimmune thyroiditis. This test measures the level of thyroid antibodies in your blood.
Second-trimester prenatal screening includes several blood tests that assess the risk of having a baby with certain genetic conditions or birth defects. Screening is usually done between the 14th and 22nd weeks of pregnancy (the 16th to 18th is ideal). A triple test includes AFP, hCG, and Estriol. Any abnormal result requires more testing. Usually, an ultrasound, or even an amniocentesis, may be needed for an accurate diagnosis.
loading.svg